vs

Side-by-side financial comparison of Farmmi, Inc. (FAMI) and PEDEVCO CORP (PED). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $16.1M, roughly 1.4× Farmmi, Inc.). Farmmi, Inc. runs the higher net margin — -0.3% vs -36.8%, a 36.6% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs -55.7%).

Farmmi Inc. is a company that processes and sells agricultural products in China and abroad; it grows and markets shiitake and wood ear mushrooms and other edible fungi products, including bamboo fungi, chestnut mushroom, trumpet royale, hen of the woods, lawyer's wig, and lion's mane mushroom. It also operates Farmmi Jicai, an online store that sells edible fungi products under the Forasen and Farmmi Liangpin brands. In addition, the company exports dried whole and sliced shiitake mushrooms,...

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

FAMI vs PED — Head-to-Head

Bigger by revenue
PED
PED
1.4× larger
PED
$23.1M
$16.1M
FAMI
Growing faster (revenue YoY)
PED
PED
+173.9% gap
PED
118.2%
-55.7%
FAMI
Higher net margin
FAMI
FAMI
36.6% more per $
FAMI
-0.3%
-36.8%
PED

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
FAMI
FAMI
PED
PED
Revenue
$16.1M
$23.1M
Net Profit
$-44.0K
$-8.5M
Gross Margin
5.0%
Operating Margin
-4.1%
-21.3%
Net Margin
-0.3%
-36.8%
Revenue YoY
-55.7%
118.2%
Net Profit YoY
-107.0%
-243.5%
EPS (diluted)
$-0.04
$-2.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FAMI
FAMI
PED
PED
Q4 25
$23.1M
Q3 25
$7.0M
Q2 25
$7.0M
Q1 25
$16.1M
$8.7M
Q4 24
$10.6M
Q3 24
$9.1M
Q2 24
$11.8M
Q1 24
$36.4M
$8.1M
Net Profit
FAMI
FAMI
PED
PED
Q4 25
$-8.5M
Q3 25
$-325.0K
Q2 25
$-1.7M
Q1 25
$-44.0K
$140.0K
Q4 24
$5.9M
Q3 24
$2.9M
Q2 24
$2.7M
Q1 24
$630.5K
$773.0K
Gross Margin
FAMI
FAMI
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
5.0%
Q4 24
Q3 24
Q2 24
Q1 24
5.9%
Operating Margin
FAMI
FAMI
PED
PED
Q4 25
-21.3%
Q3 25
-12.0%
Q2 25
-32.2%
Q1 25
-4.1%
1.7%
Q4 24
-12.9%
Q3 24
31.3%
Q2 24
22.3%
Q1 24
2.5%
7.6%
Net Margin
FAMI
FAMI
PED
PED
Q4 25
-36.8%
Q3 25
-4.7%
Q2 25
-24.0%
Q1 25
-0.3%
1.6%
Q4 24
56.0%
Q3 24
32.2%
Q2 24
22.7%
Q1 24
1.7%
9.5%
EPS (diluted)
FAMI
FAMI
PED
PED
Q4 25
$-2.23
Q3 25
$0.00
Q2 25
$-0.02
Q1 25
$-0.04
$0.00
Q4 24
$2.69
Q3 24
$0.03
Q2 24
$0.03
Q1 24
$1.20
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FAMI
FAMI
PED
PED
Cash + ST InvestmentsLiquidity on hand
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$166.4M
$207.4M
Total Assets
$230.4M
$375.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FAMI
FAMI
PED
PED
Q4 25
$3.2M
Q3 25
$10.9M
Q2 25
$8.5M
Q1 25
$10.4M
Q4 24
$4.0M
Q3 24
$4.6M
Q2 24
$6.1M
Q1 24
$13.3M
Stockholders' Equity
FAMI
FAMI
PED
PED
Q4 25
$207.4M
Q3 25
$115.4M
Q2 25
$115.2M
Q1 25
$166.4M
$116.2M
Q4 24
$115.6M
Q3 24
$106.5M
Q2 24
$103.2M
Q1 24
$164.4M
$100.0M
Total Assets
FAMI
FAMI
PED
PED
Q4 25
$375.9M
Q3 25
$135.9M
Q2 25
$136.8M
Q1 25
$230.4M
$145.6M
Q4 24
$128.3M
Q3 24
$114.3M
Q2 24
$111.0M
Q1 24
$171.9M
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FAMI
FAMI
PED
PED
Operating Cash FlowLast quarter
$14.6M
$-2.1M
Free Cash FlowOCF − Capex
$14.6M
FCF MarginFCF / Revenue
90.1%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FAMI
FAMI
PED
PED
Q4 25
$-2.1M
Q3 25
$7.4M
Q2 25
$-420.0K
Q1 25
$14.6M
$5.9M
Q4 24
$4.2M
Q3 24
$8.3M
Q2 24
$4.6M
Q1 24
$-14.9M
$-4.3M
Free Cash Flow
FAMI
FAMI
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
$14.6M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
FAMI
FAMI
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
90.1%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
FAMI
FAMI
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
0.1%
Q4 24
Q3 24
Q2 24
Q1 24
0.0%
Cash Conversion
FAMI
FAMI
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
42.34×
Q4 24
0.71×
Q3 24
2.83×
Q2 24
1.71×
Q1 24
-23.63×
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons